//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Co-founder & editor, Works in Progress. Writer, Scientific Discovery. Podcaster, Hard Drugs. Advisor, Coefficient Giving. // Previously at Our World in Data. Newsletter: https://scientificdiscovery.dev Podcast: https://harddrugs.worksinprogress.co 🏳️‍🌈
Saloni









Loading...
“[T]he breakthroughs we’re seeing today are a lagging indicator of inputs into the pipeline: they reflect choices people made in the past. We’ll only be able to see the gaps created by reduced investment in retrospect, years from now, […]”
New post! @nikomccarty.bsky.social and I have been writing regular round ups for a little while now, but so much has happened recently that this month’s post feels like it contains a year’s worth of breakthroughs. Read it here!
New post! @nikomccarty.bsky.social and I have been writing regular round ups for a little while now, but so much has happened recently that this month’s post feels like it contains a year’s worth of breakthroughs. Read it here!
7h
🚨 A few months ago, a paper published in Science reported that “LLM adoption is associated with a large increase in researchers’ scientific output.” In a comment released today, we show that the reported effects are driven by a methodological issue in the empirical design. arxiv.org/abs/2605.17979
New short blogpost! I wrote a round up of cancer research news from ASCO2026: - Daraxonrasib, the breakthrough pancreatic cancer drug - Big 7-year results of lorlatinib for ALK+ lung cancers – Talazoparib, a prostate cancer drug that cut the risk of progression by half and much more. Read here:
Every time I visit my parents, they're like "So when's the date for YOUR wedding?" And I answer "Yesterday, you weren't invited."
Wow this is awesome. @aaronjbecker.bsky.social created an animated baby boom ridgeline chart inspired by mine!
Claude Fable's "biosecurity" flags are incredibly restrictive. This model is going to be almost useless for me.